Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64–80. https://doi.org/10.1016/S0140-6736(19)30956-0.

Article  PubMed  Google Scholar 

You R, Liu YP, Huang PY, Zou X, Sun R, He YX, Wu YS, Shen GP, Zhang HD, Duan CY, Tan SH, Cao JY, Li JB, Xie YL, Zhang YN, Wang ZQ, Yang Q, Lin M, Jiang R, Zhang M, Hua X, Tang YJ, Zhuang LQ, Chen AH, Guo QY, Mo L, Chen HY, Mai Y, Ling HQ, Liu L, Chua Q, Chen MLK. Efficacy and safety of locoregional radiotherapy with chemotherapy vs chemotherapy alone in de novo metastatic nasopharyngeal carcinoma: a multicenter phase 3 randomized clinical trial. JAMA Oncol. 2020;6:1345–52. https://doi.org/10.1001/jamaoncol.2020.1808.

Article  PubMed  PubMed Central  Google Scholar 

Zhang CX, Ye SB, Ni JJ, Cai TT, Liu YN, Huang DJ, Mai HQ, Chen QY, He J, Zhang XS, Zeng YX, Li J, Cui J. STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion. Cell Death Differ. 2019;26:2314–28. https://doi.org/10.1038/s41418-019-0302-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19:108–19. https://doi.org/10.1038/s41590-017-0022-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao X, Zhao R, Wen J, Zhang X, Wu S, Fang J, et al. Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment. Med Oncol. 2024;41:96. https://doi.org/10.1007/s12032-024-02357-x.

Article  CAS  PubMed  Google Scholar 

Gunes EG, Rosen ST, Querfeld C. The role of myeloid-derived suppressor cells in hematologic malignancies. Curr Opin Oncol. 2020;32:518–26. https://doi.org/10.1097/CCO.0000000000000662.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jalil AT, Abdulhadi MA, Al-Marzook FA, Hizam MM, Abdulameer SJ, Al-Azzawi AKJ, et al. NK cells direct the perspective approaches to cancer immunotherapy. Med Oncol. 2023;40:206. https://doi.org/10.1007/s12032-023-02066-x.

Article  PubMed  Google Scholar 

Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1 + myeloid cells. J Immunol. 2001;166:5398–406. https://doi.org/10.4049/jimmunol.166.9.5398.

Article  CAS  PubMed  Google Scholar 

Zhou HY, Jiang MY, Yuan HY, Ni WH, Tai GX. Dual roles of myeloid-derived suppressor cells induced by toll-like receptor signaling in cancer. Oncol Lett. 2021;21:149. https://doi.org/10.3892/ol.2020.12410.

Article  CAS  PubMed  Google Scholar 

Zhu CJ, Wei YQ, Wei XW. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. Mol Cancer. 2019;18:153. https://doi.org/10.1186/s12943-019-1090-3.

Article  PubMed  PubMed Central  Google Scholar 

Bhalla S, Gerber DE. AXL inhibitors: Status of Clinical Development. Curr Oncol Rep. 2023;25:521–9. https://doi.org/10.1007/s11912-023-01392-7.

Article  PubMed  PubMed Central  Google Scholar 

Zhou KF, Zhao J, Xu HJ, Yan XJ, Liu WD, Jiang XJ, Ren CP. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47:685–97. https://doi.org/10.11817/j.issn.1672-7347.2022.210786.

Article  PubMed  Google Scholar 

Ludwig KF, Du WT, Sorrelle NB, Wnuk-Lipinska K, Topalovski M, Toombs JE, Cruz VH, Yabuuchi S, Rajeshkumar NV, Maitra A, Lorens JB, Brekken RA. Small-molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer. Cancer Res. 2018;78:246–55. https://doi.org/10.1158/0008-5472.CAN-17-1973.

Article  CAS  PubMed  Google Scholar 

Holland SJ, Pan A, Franci C, Hu Y, Chang B, Li W, Duan M, Torneros A, Yu J, Heckrodt TJ, Zhang J, Ding P, Apatira A, Chua J, Brandt R, Pine P, Goff D, Singh R, Payan DG, Hitoshi Y. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 2010;70:1544–54. https://doi.org/10.1158/0008-5472.CAN-09-2997.

Article  CAS  PubMed  Google Scholar 

Engelsen AST, Lotsberg ML, Abou Khouzam R, Thiery JP, Lorens JB, Chouaib S, Terry S. Dissecting the role of AXL in cancer immune escape and resistance to immune checkpoint inhibition. Front Immunol. 2022;13:869676. https://doi.org/10.3389/fimmu.2022.869676.

Article  CAS  PubMed  PubMed Central  Google Scholar 

OuYang LY, Wu XJ, Ye SB, Zhang RX, Li ZL, Liao W, Pan ZZ, Zheng LM, Zhang XS, Wang Z, Li Q, Ma G, Li J. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer. J Transl Med. 2015;13:47. https://doi.org/10.1186/s12967-015-0410-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang SF, Zhao XY, Wu SW, Cui DW, Xu ZS. Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies. Biomark Res. 2023;11:34. https://doi.org/10.1186/s40364-023-00475-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kallberg E, Stenstrom M, Liberg D, Ivars F, Leanderson T. CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden. BMC Immunol. 2012;13:69. https://doi.org/10.1186/1471-2172-13-69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang ET, Ye WM, Zeng YX, Adami HO. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2021;30:1035–47. https://doi.org/10.1158/1055-9965.EPI-20-1702.

Article  CAS  PubMed  Google Scholar 

Su ZY, Siak PY, Lwin YY, Cheah SC. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 2024;43:919–39. https://doi.org/10.1007/s10555-024-10176-9.

Article  PubMed  Google Scholar 

Rankin EB, Giaccia AJ. The receptor tyrosine kinase AXL in cancer progression. Cancers (Basel). 2016;8:103. https://doi.org/10.3390/cancers8110103.

Article  CAS  PubMed  Google Scholar 

Yang YH, Li CY, Liu T, Dai XF, Bazhin AV. Myeloid-derived suppressor cells in tumors: from mechanisms to antigen specificity and microenvironmental regulation. Front Immunol. 2020;11:1371. https://doi.org/10.3389/fimmu.2020.01371.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6:362. https://doi.org/10.1038/s41392-021-00670-9.

Article  PubMed  PubMed Central  Google Scholar 

Tanaka M, Siemann DW. Gas6/Axl signaling pathway in the tumor immune microenvironment. Cancers (Basel). 2020;12:1850. https://doi.org/10.3390/cancers12071850.

Article  CAS  PubMed  Google Scholar 

Fultang N, Li XY, Li T, Chen YH. Myeloid-derived suppressor cell differentiation in cancer: transcriptional regulators and enhanceosome-mediated mechanisms. Front Immunol. 2020;11:619253. https://doi.org/10.3389/fimmu.2020.619253.

Article  CAS  PubMed  Google Scholar 

Duan TH, Du Y, Xing CS, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774. https://doi.org/10.3389/fimmu.2022.812774.

Article  CAS  PubMed  PubMed Central  Google Scholar